Back to Top Skip to main content Skip to sub-navigation

Place addresses DHA COVID-19 response

Lt. Gen. Ronald Place, director of the Defense Health Agency, and Rear Adm. Bruce Gillingham, surgeon general of the Navy, discuss plans for additional COVID-19 response efforts with the Pentagon Press Corps.  Lt. Gen. Ronald Place, director of the Defense Health Agency, and Rear Adm. Bruce Gillingham, surgeon general of the Navy, discuss plans for additional COVID-19 response efforts with the Pentagon Press Corps.

Recommended Content:

Combat Support | Public Health | Coronavirus | Coronavirus

Army Lt. Gen. Ronald Place, director of the Defense Health Agency, today spoke of agency efforts to address the COVID-19 pandemic within the United States in a telephonic press conference.

Appearing with Rear Adm. Bruce Gillingham, the U.S. Navy surgeon general, Place emphasized DHA’s role in supporting broader Department of Defense efforts to address the crisis, including the creation of a Crisis Action Team that works to address patient concerns, patient care, equipment availability, blood supply monitoring, and sharing DHA capabilities with those who may need them to ensure military forces maintain a high level of operational readiness.  

He also stressed DHA’s work to address pressing issues, such as availability of bed spaces; military health capabilities and capacity; the trade-offs of shifting resources from one need to another; assisting people with self-screening; and triage and testing of patients.

Place said within the Military Health System, experts are evaluating reducing elective procedures in the interest of safety and capacity, and has directed doctors and nurses in staff positions to shift responsibilities to clinical patient care as much as possible. DHA is also investigating how clinics and hospitals might be able to surge bed spaces that aren’t currently being used for patient care.

“I want to note how much we appreciate the military community’s positive attitude and particular resilience even as they shoulder their burden of stress, inconvenience, and disruption to their health care during this crisis,” Place said in his opening statement.

Following is the complete opening statement and transcript of the press conference:


Today I want to give you an update on the Defense Health Agency’s and the Military Health System’s support to the national COVID-19 response. Thanks to Mr Hoffman for hosting us virtually and for the teams of folks who make this possible. And thank you to RADM Gillingham, here with me, for making himself available to talk specific to Navy issues, especially about the USNS COMFORT and MERCY.

Mostly, thanks to the reporters here and on the phone, for your attendance and attention to the very important work of the Defense Health Agency. Whatever questions we can’t answer in the time we have scheduled, we’ll be sure to take for action to get back to you as soon as we can.

First, a little context. The Defense Health Agency serves daily 9.5M beneficiaries of the military’s TRICARE health care system—that includes about 1.5M active-duty military personnel.  It also includes their family members, Reservists and the military retiree population. DHA is responsible for the providing care through 51 hospitals, and 424 military treatment clinics – and, of course, the USNS COMFORT and USNS MERCY. 

I don’t want to go further without noting that care in these facilities for our beneficiaries is being significantly affected by the nationwide response. And I want to note how much we appreciate the military community’s positive attitude and particular resilience even as they shoulder their burden of stress, inconvenience, and disruption to their healthcare during this crisis.

Briefly, what we’re talking about here is how DHA is providing support through the Department of Defense to the whole of government response. We’ve put in place a Crisis Action Team that is working nights and weekends here at our headquarters--on patient concerns, patient care, equipment, monitoring blood supply and sharing our capabilities for the greater cause—all while ensuring we maintain the readiness of our military forces.

And we’re looking at issues that have become familiar to you by now: bed space; military health capabilities and capacity; the trade-offs of shifting resources from one need to another; assisting people with self-screening; and triage and testing of patients.

One statistic that helps tell the story relates to calls we are receiving to our Nurse Advice line – which has jumped to about 500 percent in just a few days, to where we are now fielding about 8,000 calls a day.

Within our system, we are evaluating reducing elective procedures, to increase capacity, and I’ve directed doctors and nurses in staff positions to shift responsibilities to clinical patient care, as much as possible. We’re looking at how our clinics and hospitals might be able surge bed space that isn’t currently being used for patient care. And the list goes on.

I think RADM Gillingham’s description of the issues that arise in mobilizing the COMFORT and MERCY will really be the most tangible way for you to get a sense of how we are approaching these complex issues in real time, so that we’re not just tossing out numbers and jargon at you.

And with that, we’ll take your questions.


You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy

U.S. Navy/U.S. Marine Corps COSC Policy Update

Policy
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.